The Human Tissue (Authorisation) (Specified Type A Procedures) (Scotland) Regulations 2020
The Scottish Ministers make the following Regulations in exercise of the powers conferred by sections 16B(1) and (2) of the Human Tissue (Scotland) Act 2006 M1 and all other powers enabling them to do so.
In accordance with section 16B(4) of that Act they have consulted with such persons as they consider appropriate.
In accordance with section 59(3)(ad) M2 of that Act, a draft of this instrument has been laid before and approved by resolution of the Scottish Parliament.
Citation and commencement1.
These Regulations may be cited as the Human Tissue (Authorisation) (Specified Type A Procedures) (Scotland) Regulations 2020 and come into force on the day on which section 23 of the Human Tissue (Authorisation) (Scotland) Act 2019 M3 comes into force for all purposes.
Type A procedures2.
The pre-death procedures specified in the second column of the table in the schedule are specified as Type A procedures for the purposes of sections 16D to 16F of the Human Tissue (Scotland) Act 2006 M4.
St Andrew's House,
Edinburgh
SCHEDULESpecification of Pre-Death Procedures
1.
In this schedule—
“arterial line” means a cannula inserted into an artery,
“blood component” means any of the following constituents of human blood—
red cells,
white cells,
platelets, and
plasma,
“blood product” means any therapeutic product derived from human blood or plasma,
“intravenous fluids” means any electrolyte solution intended for intravenous administration,
“pre-established airway and ventilatory support” means any method of airway or ventilatory support administered to the person for the primary purpose of the person's medical treatment prior to any decision to withdraw life sustaining treatment,
“pre-established suprapubic catheter” means a suprapubic catheter inserted into the person for the primary purpose of the person's medical treatment prior to any decision to withdraw life sustaining treatment.
Class of procedure | Type of procedure |
|---|---|
Collection of bodily fluids and microbiological samples | Taking of a blood sample |
Taking of a urine sample including by way of a pre-established suprapubic catheter | |
Taking of a chest secretion sample (excluding bronchoscopy) | |
Swabbing or scraping of the body including inside of the mouth, nostril or ear canal but excluding the swabbing or scraping of any part of any other body orifice | |
Radiological imaging | Carrying out of an X-Ray without transferring the person from their existing location |
Carrying out of ultrasound imaging without transferring the person from their existing location | |
Carrying out of transthoracic echocardiography without transferring the person from their existing location | |
Cardiovascular monitoring | Carrying out of electrocardiogram |
Cardiac output monitoring by way of an arterial line | |
Carrying out of central venous pressure monitoring | |
Arterial blood pressure monitoring including by way of an arterial line | |
Respiratory monitoring and support | Measuring of oxygen saturation |
Sustaining the appropriate operation of any pre-established airway and ventilatory support | |
Administration of medication or other product | Administration of antimicrobials |
Administration of intravenous fluids | |
Administration of medication to manage blood pressure | |
Administration of blood, blood components and blood products |
(This note is not part of the Regulations)
These Regulations specify medical procedures which may be carried out on a person for the purpose of increasing the likelihood of successful transplantation of a part of the person's body after the person's death and which are not for the primary purpose of safeguarding or promoting the physical or mental health of the person, known under the Human Tissue (Scotland) Act 2006 (“the Act”) as “pre-death procedures” (see section 16A inserted by section 23 of the Human Tissue (Authorisation) (Scotland) Act 2019).
These Regulations specify the “Type A procedures”. Type A procedures are those pre-death procedures which Ministers consider are appropriate to be carried out in accordance with section 16E of the Act without the need for further conditions or restrictions on their performance such as only in specified circumstances or following further authorisation.
A pre-death procedure may only be carried out on a person if it has been specified as either a Type A procedure or Type B procedure (see section 16D of the Act).
No business and regulatory impact assessment has been prepared for these Regulations as no impact upon business, charities or voluntary bodies is foreseen.